Abstract
Pyrrolizidine alkaloids (PAs) and PA N-oxides are common phytotoxins produced by over 6000 plant species. Humans are frequently exposed to PAs via ingestion of PA-containing herbal products or PA-contaminated foods. PAs require metabolic activation to form pyrrole–protein adducts and pyrrole-DNA adducts which lead to cytotoxicity and genotoxicity. Individual PAs differ in their metabolic activation patterns, which may cause significant difference in toxic potency of different PAs. This review discusses the current knowledge and recent advances of metabolic pathways of different PAs, especially the metabolic activation and metabolism-mediated cytotoxicity and genotoxicity, and the risk evaluation methods of PA exposure. In addition, this review provides perspectives of precision toxicity assessment strategies and biomarker development for the risk control and translational investigations of human intoxication by PAs.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Allemang A, Mahony C, Lester C, Pfuhler S (2018) Relative potency of fifteen pyrrolizidine alkaloids to induce DNA damage as measured by micronucleus induction in HepaRG human liver cells. Food Chem Toxicol 121:72–81. https://doi.org/10.1016/j.fct.2018.08.003
Allen JR, Chesney CF, Frazee WJ (1972) Modifications of pyrrolizidine alkaloid intoxication resulting from altered hepatic microsomal enzymes. Toxicol Appl Pharmacol 23(3):470–479. https://doi.org/10.1016/0041-008x(72)90049-x
Aninat C, Piton A, Glaise D et al (2006) Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells. Drug Metab Dispos 34(1):75–83. https://doi.org/10.1124/dmd.105.006759
Anjos BL, Nobre VM, Dantas AF et al (2010) Poisoning of sheep by seeds of Crotalaria retusa: acquired resistance by continuous administration of low doses. Toxicon 55(1):28–32. https://doi.org/10.1016/j.toxicon.2009.06.028
Beuerle T, Benford D, Brimer L et al (2011) Scientific opinion on pyrrolizidine alkaloids in food and feed. EFSA J 9(11):1–134
Bordet T, Berna P, Abitbol JL, Pruss RM (2010) Olesoxime (TRO19622): a novel mitochondrial-targeted neuroprotective compound. Pharmaceuticals (Basel) 3(2):345–368. https://doi.org/10.3390/ph3020345
Buhler DR, Kedzierski B (1986) Biological reactive intermediates of pyrrolizidine alkaloids. Adv Exp Med Biol 197:611–620. https://doi.org/10.1007/978-1-4684-5134-4_57
Buhler DR, Miranda CL, Kedzierski B, Reed RL (1991) Mechanisms for pyrrolizidine alkaloid activation and detoxification. Adv Exp Med Biol 283:597–603. https://doi.org/10.1007/978-1-4684-5877-0_75
Cao Y, Colegate SM, Edgar JA (2008) Safety assessment of food and herbal products containing hepatotoxic pyrrolizidine alkaloids: interlaboratory consistency and the importance of N-oxide determination. Phytochem Anal 19(6):526–533. https://doi.org/10.1002/pca.1079
Castagnoli N Jr, Rimoldi JM, Bloomquist J, Castagnoli KP (1997) Potential metabolic bioactivation pathways involving cyclic tertiary amines and azaarenes. Chem Res Toxicol 10(9):924–940. https://doi.org/10.1021/tx970096j
CDC (2012) Investigating liver disease in Ethiopia. Centers for Disease Control and Prevention. https://www.cdc.gov/nceh/stories/ethiopia.html. Accessed 12 Aug 2020
Chan PC, Mahler J, Bucher JR, Travlos GS, Reid JB (1994) Toxicity and carcinogenicity of riddelliine following 13 weeks of treatment to rats and mice. Toxicon 32(8):891–908. https://doi.org/10.1016/0041-0101(94)90368-9
Chan PC, Haseman JK, Prejean JD, Nyska A (2003) Toxicity and carcinogenicity of riddelliine in rats and mice. Toxicol Lett 144(3):295–311. https://doi.org/10.1016/s0378-4274(03)00240-6
Chauvin P, Dillon JC, Moren A, Talbak S, Barakaev S (1993) Heliotrope poisoning in Tadjikistan. Lancet 342(8861):246–247. https://doi.org/10.1016/0140-6736(93)90798-l
Cheeke PR (1988) Toxicity and metabolism of pyrrolizidine alkaloids. J Anim Sci 66(9):2343–2350. https://doi.org/10.2527/jas1988.6692343x
Cheeke PR, Pierson-Goeger ML (1983) Toxicity of Senecio jacobaea and pyrrolizidine alkaloids in various laboratory animals and avian species. Toxicol Lett 18(3):343–349. https://doi.org/10.1016/0378-4274(83)90116-9
Chen MX, Li L, Zhong DF, Shen SJ, Zheng J, Chen XY (2016) 9-Glutathiony1-6,7-dihydro-1-hydroxymethy1-5H-pyrrolizine is the major pyrrolic glutathione conjugate of retronecine-type pyrrolizidine alkaloids in liver microsomes and in rats. Chem Res Toxicol 29(2):180–189. https://doi.org/10.1021/acs.chemrestox.5b00427
Chiu C, Martin C, Woldemichael D et al (2016) Surveillance of a chronic liver disease of unidentified cause in a rural setting of Ethiopia: a case study. Ethiop Med J 54(1):27–32
Chojkier M (2003) Hepatic sinusoidal-obstruction syndrome: toxicity of pyrrolizidine alkaloids. J Hepatol 39(3):437–446. https://doi.org/10.1016/s0168-8278(03)00231-9
Chou MW, Wang YP, Yan J et al (2003a) Riddelliine N-oxide is a phytochemical and mammalian metabolite with genotoxic activity that is comparable to the parent pyrrolizidine alkaloid riddelliine. Toxicol Lett 145(3):239–247. https://doi.org/10.1016/S0378-4274(03)00293-5
Chou MW, Yan J, Nichols J et al (2003b) Correlation of DNA adduct formation and riddelliine-induced liver tumorigenesis in F344 rats and B6C3F(1) mice. Cancer Lett 193(2):119–125. https://doi.org/10.1016/S0304-3835(03)00045-4
Chu PS, Lame MW, Segall HJ (1993) In vivo metabolism of retrorsine and retrorsine-N-oxide. Arch Toxicol 67(1):39–43. https://doi.org/10.1007/BF02072033
Chung WG, Buhler DR (1994) The effect of spironolactone treatment on the cytochrome P450-mediated metabolism of the pyrrolizidine alkaloid senecionine by hepatic microsomes from rats and guinea pigs. Toxicol Appl Pharmacol 127(2):314–319. https://doi.org/10.1006/taap.1994.1167
Chung WG, Buhler DR (1995) Major factors for the susceptibility of guinea-pig to the pyrrolizidine alkaloid jacobine. Drug Metab Dispos 23(11):1263–1267
Chung WG, Miranda CL, Buhler DR (1995) A cytochrome p4502b form is the major bioactivation enzyme for the pyrrolizidine alkaloid senecionine in guinea-pig. Xenobiotica 25(9):929–939. https://doi.org/10.3109/00498259509046664
Cooper RA, Huxtable RJ (1999) The relationship between reactivity of metabolites of pyrrolizidine alkaloids and extrahepatic toxicity. Proc West Pharmacol Soc 42:13–16
Coulombe RA, Drew GL, Stermitz FR (1999) Pyrrolizidine alkaloids crosslink DNA with actin. Toxicol Appl Pharmacol 154(2):198–202. https://doi.org/10.1006/taap.1998.8552
Dai D, Tang J, Rose R et al (2001) Identification of variants of CYP3A4 and characterization of their abilities to metabolize testosterone and chlorpyrifos. J Pharmacol Exp Ther 299(3):825–831
Deinzer ML, Thomson PA, Burgett DM, Isaacson DL (1977) Pyrrolizidine alkaloids—their occurrence in honey from tansy ragwort (Senecio jacobaea L.). Science 195(4277):497–499. https://doi.org/10.1126/science.835011
DeLeve LD, Kaplowitz N (1991) Glutathione metabolism and its role in hepatotoxicity. Pharmacol Ther 52(3):287–305. https://doi.org/10.1016/0163-7258(91)90029-l
DeLeve LD, Wang XD, Kuhlenkamp JF, Kaplowitz N (1996) Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venoocclusive disease. Hepatology 23(3):589–599. https://doi.org/10.1002/hep.510230326
DeLeve LD, McCuskey RS, Wang X et al (1999) Characterization of a reproducible rat model of hepatic veno-occlusive disease. Hepatology 29(6):1779–1791. https://doi.org/10.1002/hep.510290615
DeLeve LD, Shulman HM, McDonald GB (2002) Toxic injury to hepatic sinusoids: sinusoidal obstruction syndrome (veno-occlusive disease). Semin Liver Dis 22(1):27–41. https://doi.org/10.1055/S-2002-23204
DeLeve LD, Ito Y, Bethea NW, McCuskey MK, Wang XD, McCuskey RS (2003a) Embolization by sinusoidal lining cells obstructs the microcirculation in rat sinusoidal obstruction syndrome. Am J Physiol Gastrointest Liver Physiol 284(6):G1045–G1052. https://doi.org/10.1152/ajpgi.00526.2002
DeLeve LD, Wang XD, Kanel GC et al (2003b) Decreased hepatic nitric oxide production contributes to the development of rat sinusoidal obstruction syndrome. Hepatology 38(4):900–908. https://doi.org/10.1053/jhep.2003.50383
DeLeve LD, Wang XD, Tsai J, Kanel G, Strasberg S, Tokes ZA (2003c) Sinusoidal obstruction syndrome (veno-occlusive disease) in the rat is prevented by matrix metalloproteinase inhibition. Gastroenterology 125(3):882–890. https://doi.org/10.1016/S0016-5085(03)01056-4
Dueker SR, Lame MW, Morin D, Wilson DW, Segall HJ (1992a) Guinea-pig and rat hepatic-microsomal metabolism of monocrotaline. Drug Metab Dispos 20(2):275–280
Dueker SR, Lame MW, Segall HJ (1992b) Hydrolysis of pyrrolizidine alkaloids by guinea pig hepatic carboxylesterases. Toxicol Appl Pharmacol 117(1):116–121. https://doi.org/10.1016/0041-008x(92)90225-h
Dueker SR, Lame MW, Segall HJ (1995) Hydrolysis rates of pyrrolizidine alkaloids derived from Senecio jacobaea. Arch Toxicol 69(10):725–728. https://doi.org/10.1007/s002040050240
Ebmeyer J, Braeuning A, Glatt H, These A, Hessel-Pras S, Lampen A (2019) Human CYP3A4-mediated toxification of the pyrrolizidine alkaloid lasiocarpine. Food Chem Toxicol 130:79–88. https://doi.org/10.1016/j.fct.2019.05.019
Ebmeyer J, Rasinger JD, Hengstler JG et al (2020) Hepatotoxic pyrrolizidine alkaloids induce DNA damage response in rat liver in a 28-day feeding study. Arch Toxicol 94(5):1739–1751. https://doi.org/10.1007/s00204-020-02779-2
Edgar JA, Molyneux RJ, Colegate SM (2015) Pyrrolizidine alkaloids: potential role in the etiology of cancers, pulmonary hypertension, congenital anomalies, and liver disease. Chem Res Toxicol 28(1):4–20. https://doi.org/10.1021/tx500403t
EFSA (2017) Update: use of the benchmark dose approach in risk assessment. EFSA J 15(1):1–41
Estep JE, Lame MW, Jones AD, Segall HJ (1990) N-Acetylcysteine-conjugated pyrrole identified in rat urine following administration of 2 pyrrolizidine alkaloids, monocrotaline and senecionine. Toxicol Lett 54(1):61–69. https://doi.org/10.1016/0378-4274(90)90056-R
Fashe MM, Juvonen RO, Petsalo A, Rasanen J, Pasanen M (2015) Species-specific differences in the in vitro metabolism of lasiocarpine. Chem Res Toxicol 28(10):2034–2044. https://doi.org/10.1021/acs.chemrestox.5b00253
Field RA, Stegelmeier BL, Colegate SM, Brown AW, Green BT (2015) An in vitro comparison of the cytotoxic potential of selected dehydropyrrolizidine alkaloids and some N-oxides. Toxicon 97:36–45. https://doi.org/10.1016/j.toxicon.2015.02.001
Fox DW, Hart MC, Bergeson PS, Jarrett PB, Stillman AE, Huxtable RJ (1978) Pyrrolizidine (Senecio) intoxication mimicking Reye syndrome. J Pediatr 93(6):980–982. https://doi.org/10.1016/s0022-3476(78)81227-x
Fu PP, Chou MW, Xia Q et al (2001) Genotoxic pyrrolizidine alkaloids and pyrrolizidine alkaloid N-oxides—mechanisms leading to DNA adduct formation and tumorigenicity. J Environ Sci Health C 19(2):353–385. https://doi.org/10.1081/Gnc-100107580
Fu PP, Xia Q, Lin G, Chou MW (2004) Pyrrolizidine alkaloids—genotoxicity, metabolism enzymes, metabolic activation, and mechanisms. Drug Metab Rev 36(1):1–55. https://doi.org/10.1081/Dmr-120028426
Fu PP, Xia Q, Chou MW, Lin G (2007) Detection, hepatotoxicity, and tumorigenicity of pyrrolizidine alkaloids in Chinese herbal plants and herbal dietary supplements. J Food Drug Anal 15(4):400–415. https://doi.org/10.38212/2224-6614.2392
Fu PP, Xia Q, He X et al (2017) Detection of pyrrolizidine alkaloid DNA adducts in livers of cattle poisoned with Heliotropium europaeum. Chem Res Toxicol 30(3):851–858. https://doi.org/10.1021/acs.chemrestox.6b00456
Gao H, Li N, Wang JY, Zhang SC, Lin G (2012) Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids. J Digest Dis 13(1):33–39. https://doi.org/10.1111/j.1751-2980.2011.00552.x
Gao H, Ruan J, Chen J et al (2015) Blood pyrrole-protein adducts as a diagnostic and prognostic index in pyrrolizidine alkaloid-hepatic sinusoidal obstruction syndrome. Drug Des Dev Ther 9:4861–4868. https://doi.org/10.2147/DDDT.S87858
Gao L, Rutz L, Schrenk D (2020) Structure-dependent hepato-cytotoxic potencies of selected pyrrolizidine alkaloids in primary rat hepatocyte culture. Food Chem Toxicol 135:110923. https://doi.org/10.1016/j.fct.2019.110923
Geburek I, Schrenk D, These A (2020) In vitro biotransformation of pyrrolizidine alkaloids in different species: part II-identification and quantitative assessment of the metabolite profile of six structurally different pyrrolizidine alkaloids. Arch Toxicol 94(11):3759–3774. https://doi.org/10.1007/s00204-020-02853-9
Ghosal A, Satoh H, Thomas PE, Bush E, Moore D (1996) Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450. Drug Metab Dispos 24(9):940–947
Gilruth J (1903) Hepatic cirrhosis affecting horses and cattle (so-called “Winton disease”). New Zealand Department of Agriculture, pp 228–279
Gilruth J (1904) Hepatic cirrhosis due to ragwort (Senecio jacobaea). John Mackay
Gluck J, Waizenegger J, Braeuning A, Hessel-Pras S (2020) Pyrrolizidine alkaloids induce cell death in human heparg cells in a structure-dependent manner. Int J Mol Sci 22(1):202. https://doi.org/10.3390/ijms22010202
Guengerich FP (1999) Cytochrome P-450 3A4: regulation and role in drug metabolism. Annu Rev Pharmacol Toxicol 39:1–17. https://doi.org/10.1146/annurev.pharmtox.39.1.1
Guo L, Mei N, Dial S, Fuscoe J, Chen T (2007) Comparison of gene expression profiles altered by comfrey and riddelliine in rat liver. BMC Bioinform 8:S22. https://doi.org/10.1186/1471-2105-8-S7-S22
Hadi NSA, Bankoglu EE, Schott L et al (2021) Genotoxicity of selected pyrrolizidine alkaloids in human hepatoma cell lines HepG2 and Huh6. Mutat Res Genet Toxicol Environ 861–862:503305. https://doi.org/10.1016/j.mrgentox.2020.503305
Hakkola J, Hukkanen J, Turpeinen M, Pelkonen O (2020) Inhibition and induction of CYP enzymes in humans: an update. Arch Toxicol 94(11):3671–3722. https://doi.org/10.1007/s00204-020-02936-7
He YQ, Liu Y, Zhang BF et al (2010a) Identification of the UDP-glucuronosyltransferase isozyme involved in senecionine glucuronidation in human liver microsomes. Drug Metab Dispos 38(4):626–634. https://doi.org/10.1124/dmd.109.030460
He YQ, Yang L, Liu HX et al (2010b) Glucuronidation, a new metabolic pathway for pyrrolizidine alkaloids. Chem Res Toxicol 23(3):591–599. https://doi.org/10.1021/tx900328f
He X, Xia Q, Ma L, Fu PP (2016a) 7-Cysteine-pyrrole conjugate: a new potential DNA reactive metabolite of pyrrolizidine alkaloids. J Environ Sci Health C 34(1):57–76. https://doi.org/10.1080/10590501.2015.1135593
He X, Ma L, Xia Q, Fu PP (2016b) 7-N-acetylcysteine-pyrrole conjugate-A potent DNA reactive metabolite of pyrrolizidine alkaloids. J Food Drug Anal 24(4):682–694. https://doi.org/10.1016/j.jfda.2016.08.001
He X, Xia Q, Fu PP (2017) 7-Glutathione-pyrrole and 7-cysteine-pyrrole are potential carcinogenic metabolites of pyrrolizidine alkaloids. J Environ Sci Health C. https://doi.org/10.1080/10590501.2017.1298358
He X, Xia Q, Shi Q, Fu PP (2020a) Effects of glutathione and cysteine on pyrrolizidine alkaloid-induced hepatotoxicity and DNA adduct formation in rat primary hepatocytes. J Environ Sci Health C 38(2):109–123. https://doi.org/10.1080/26896583.2020.1738161
He X, Xia Q, Zhao Y, Fu PP (2020b) 1-Formyl-7-hydroxy-6,7-dihydro-5H-pyrrolizine (1-CHO-DHP)-cysteine conjugates: metabolic formation and binding to cellular DNA. Chem Res Toxicol 33(8):2139–2146. https://doi.org/10.1021/acs.chemrestox.0c00143
He Y, Zhu L, Ma J et al (2020c) Comprehensive investigation and risk study on pyrrolizidine alkaloid contamination in Chinese retail honey. Environ Pollut 267:115542. https://doi.org/10.1016/j.envpol.2020.115542
He Y, Shi M, Wu X et al (2021a) Mutational signature analysis reveals widespread contribution of pyrrolizidine alkaloid exposure to human liver cancer. Hepatology. https://doi.org/10.1002/HEP.31723
He Y, Lian W, Ding L et al (2021b) Lung injury induced by pyrrolizidine alkaloids depends on metabolism by hepatic cytochrome P450s and blood transport of reactive metabolites. Arch Toxicol 95(1):103–116. https://doi.org/10.1007/s00204-020-02921-0
Hessel-Pras S, Braeuning A, Guenther G et al (2020) The pyrrolizidine alkaloid senecionine induces CYP-dependent destruction of sinusoidal endothelial cells and cholestasis in mice. Arch Toxicol 94(1):219–229. https://doi.org/10.1007/s00204-019-02582-8
Hincks JR, Coulombe RA (1989) Rapid detection of dna interstrand and dna protein cross-links in mammalian-cells by gravity-flow alkaline elution. Environ Mol Mutagen 13(3):211–217. https://doi.org/10.1002/em.2850130304
Hincks JR, Kim HY, Segall HJ, Molyneux RJ, Stermitz FR, Coulombe RA (1991) DNA cross-linking in mammalian-cells by pyrrolizidine alkaloids—structure–activity-relationships. Toxicol Appl Pharmacol 111(1):90–98. https://doi.org/10.1016/0041-008x(91)90137-4
Hirono I, Mori H, Haga M (1978) Carcinogenic activity of Symphytum officinale. JNCI J Natl Cancer Inst 61(3):865–868
Hong HL, Ton TV, Devereux TR et al (2003) Chemical-specific alterations in ras, p53, and beta-catenin genes in hemangiosarcomas from B6C3F1 mice exposed to o-nitrotoluene or riddelliine for 2 years. Toxicol Appl Pharmacol 191(3):227–234. https://doi.org/10.1016/S0041-008x(03)00165-0
Hosokawa M, Maki T, Satoh T (1990) Characterization of molecular species of liver microsomal carboxylesterases of several animal species and humans. Arch Biochem Biophys 277(2):219–227. https://doi.org/10.1016/0003-9861(90)90572-g
Huan JY, Miranda CL, Buhler DR, Cheeke PR (1998a) The roles of CYP3A and CYP2B isoforms in hepatic bioactivation and detoxification of the pyrrolizidine alkaloid senecionine in sheep and hamsters. Toxicol Appl Pharmacol 151(2):229–235. https://doi.org/10.1006/taap.1998.8482
Huan JY, Miranda CL, Buhler DR, Cheeke PR (1998b) Species differences in the hepatic microsomal enzyme metabolism of the pyrrolizidine alkaloids. Toxicol Lett 99(2):127–137. https://doi.org/10.1016/s0378-4274(98)00152-0
Huang MN, Yu W, Teoh WW et al (2017) Genome-scale mutational signatures of aflatoxin in cells, mice, and human tumors. Genome Res 27(9):1475–1486. https://doi.org/10.1101/gr.220038.116
Huxtable RJ (1980) Herbal teas and toxins—novel aspects of pyrrolizidine poisoning in the United-States. Perspect Biol Med 24(1):1–14
Huxtable RJ, Yan CC, Wild S, Maxwell S, Cooper R (1996) Physicochemical and metabolic basis for the differing neurotoxicity of the pyrrolizidine alkaloids, trichodesmine and monocrotaline. Neurochem Res 21(2):141–146. https://doi.org/10.1007/BF02529131
Kakar F, Akbarian Z, Leslie T et al (2010) An outbreak of hepatic veno-occlusive disease in Western afghanistan associated with exposure to wheat flour contaminated with pyrrolizidine alkaloids. J Toxicol 22:191–193. https://doi.org/10.1155/2010/313280
Karchesy JJ, Arbogast B, Deinzer ML (1987) Kinetics of alkylation reactions of pyrrolizidine alkaloid pyrroles. J Org Chem 52(17):3867–3872. https://doi.org/10.1021/jo00226a027
Kasahara Y, Kiyatake K, Tatsumi K et al (1997) Bioactivation of monocrotaline by P-450 3A in rat liver. J Cardiovasc Pharm 30(1):124–129. https://doi.org/10.1097/00005344-199707000-00018
Kempf M, Beuerle T, Buhringer M et al (2008) Pyrrolizidine alkaloids in honey: risk analysis by gas chromatography-mass spectrometry. Mol Nutr Food Res 52(10):1193–1200. https://doi.org/10.1002/mnfr.200800051
Kim HY, Stermitz FR, Molyneux RJ, Wilson DW, Taylor D, Coulombe RA Jr (1993) Structural influences on pyrrolizidine alkaloid-induced cytopathology. Toxicol Appl Pharmacol 122(1):61–69. https://doi.org/10.1006/taap.1993.1172
Kim HY, Stermitz FR, Coulombe RA (1995) Pyrrolizidine alkaloid-induced dna-protein cross-links. Carcinogenesis 16(11):2691–2697. https://doi.org/10.1093/carcin/16.11.2691
Kim HY, Stermitz FR, Li JKK, Coulombe RA (1999) Comparative DNA cross-linking by activated pyrrolizidine alkaloids. Food Chem Toxicol 37(6):619–625. https://doi.org/10.1016/S0278-6915(99)00025-3
King CD, Rios GR, Green MD, Tephly TR (2000) UDP-glucuronosyltransferases. Curr Drug Metab 1(2):143–161. https://doi.org/10.2174/1389200003339171
Kolrep F, Numata J, Kneuer C et al (2018) In vitro biotransformation of pyrrolizidine alkaloids in different species. Part I: microsomal degradation. Arch Toxicol 92(3):1089–1097. https://doi.org/10.1007/s00204-017-2114-7
Kuehl P, Zhang J, Lin Y et al (2001) Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet 27(4):383–391. https://doi.org/10.1038/86882
Kuhara K, Takanashi H, Hirono I, Furuya T, Asada Y (1980) Carcinogenic activity of clivorine, a pyrrolizidine alkaloid isolated from Ligularia dentata. Cancer Lett 10(2):117–122
Lafranconi WM, Huxtable RJ (1984) Hepatic-metabolism and pulmonary toxicity of monocrotaline using isolated perfused liver and lung. Biochem Pharmacol 33(15):2479–2484
Lame MW, Jones AD, Morin D, Segall HJ (1991) Metabolism of [14C]monocrotaline by isolated perfused rat liver. Drug Metab Dispos 19(2):516–524
Lame MW, Jones AD, Wilson DW, Dunston SK, Segall HJ (2000) Protein targets of monocrotaline pyrrole in pulmonary artery endothelial cells. J Biol Chem 275(37):29091–29099. https://doi.org/10.1074/jbc.M001372200
Lame MW, Jones AD, Wilson DW, Segall HJ (2005) Monocrotaline pyrrole targets proteins with and without cysteine residues in the cytosol and membranes of human pulmonary artery endothelial cells. Proteomics 5(17):4398–4413. https://doi.org/10.1002/pmic.200402022
Lester C, Troutman J, Obringer C et al (2019) Intrinsic relative potency of a series of pyrrolizidine alkaloids characterized by rate and extent of metabolism. Food Chem Toxicol 131:110523. https://doi.org/10.1016/j.fct.2019.05.031
Li N, Xia Q, Ruan J, Fu PP, Lin G (2011) Hepatotoxicity and tumorigenicity induced by metabolic activation of pyrrolizidine alkaloids in herbs. Curr Drug Metab 12(9):823–834. https://doi.org/10.2174/138920011797470119
Li YH, Tai WCS, Xue JY et al (2015) Proteomic study of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome in rats. Chem Res Toxicol 28(9):1715–1727. https://doi.org/10.1021/acs.chemrestox.5b00113
Li W, Wang K, Lin G, Peng Y, Zheng J (2016) Lysine adduction by reactive metabolite(s) of monocrotaline. Chem Res Toxicol 29(3):333–341. https://doi.org/10.1021/acs.chemrestox.5b00488
Li YH, Tai WC, Khan I et al (2018) Toxicoproteomic assessment of liver responses to acute pyrrolizidine alkaloid intoxication in rats. J Environ Sci Health C 36(2):65–83. https://doi.org/10.1080/10590501.2018.1450186
Lin G, Cui YY, Hawes EM (1998) Microsomal formation of a pyrrolic alcohol glutathione conjugate of clivorine firm evidence for the formation of a pyrrolic metabolite of an otonecine-type pyrrolizidine alkaloid. Drug Metab Dispos 26(2):181–184
Lin G, Cui YY, Hawes EM (2000) Characterization of rat liver microsomal metabolites of clivorine, an hepatotoxic otonecine-type pyrrolizidine alkaloid. Drug Metab Dispos 28(12):1475–1483
Lin G, Cui YY, Liu XQ, Wang ZT (2002) Species differences in the in vitro metabolic activation of the hepatotoxic pyrrolizidine alkaloid clivorine. Chem Res Toxicol 15(11):1421–1428. https://doi.org/10.1021/tx0255370
Lin G, Cui YY, Liu XQ (2003) Gender differences in microsomal metabolic activation of hepatotoxic clivorine in rat. Chem Res Toxicol 16(6):768–774. https://doi.org/10.1021/tx0340302
Lin G, Wang JY, Li N et al (2011) Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum. J Hepatol 54(4):666–673. https://doi.org/10.1016/j.jhep.2010.07.031
Liu S, Shi X, Tian X, Zhang X, Sun Z, Miao L (2017) Effect of CYP3A4*1G and CYP3A5*3 polymorphisms on pharmacokinetics and pharmacodynamics of ticagrelor in healthy Chinese subjects. Front Pharmacol 8:176. https://doi.org/10.3389/fphar.2017.00176
Louisse J, Rijkers D, Stoopen G et al (2019) Determination of genotoxic potencies of pyrrolizidine alkaloids in HepaRG cells using the gammaH2AX assay. Food Chem Toxicol 131:110532. https://doi.org/10.1016/j.fct.2019.05.040
Lu Y, Ma J, Song ZJ, Ye Y, Fu PP, Lin G (2018) The role of formation of pyrrole-ATP synthase subunit beta adduct in pyrrolizidine alkaloid-induced hepatotoxicity. Arch Toxicol 92(11):3403–3414. https://doi.org/10.1007/s00204-018-2309-6
Lu Y, Ma J, Lin G (2019) Development of a two-layer transwell co-culture model for the in vitro investigation of pyrrolizidine alkaloid-induced hepatic sinusoidal damage. Food Chem Toxicol 129:391–398. https://doi.org/10.1016/j.fct.2019.04.057
Lu Y, Wong KY, Tan C, Ma J, Feng B, Lin G (2020) Establishment of a novel CYP3A4-transduced human hepatic sinusoidal endothelial cell model and its application in screening hepatotoxicity of pyrrolizidine alkaloids. J Environ Sci Health C 38(2):169–185. https://doi.org/10.1080/26896583.2020.1769409
Luckert C, Hessel S, Lenze D, Lampen A (2015) Disturbance of gene expression in primary human hepatocytes by hepatotoxic pyrrolizidine alkaloids: a whole genome transcriptome analysis. Toxicol In Vitro 29(7):1669–1682. https://doi.org/10.1016/j.tiv.2015.06.021
Ma J, Xia Q, Fu PP, Lin G (2018) Pyrrole-protein adducts—a biomarker of pyrrolizidine alkaloid-induced hepatotoxicity. J Food Drug Anal 26(3):965–972. https://doi.org/10.1016/j.jfda.2018.05.005
Ma J, Ruan J, Chen X et al (2019) Pyrrole-hemoglobin adducts, a more feasible potential biomarker of pyrrolizidine alkaloid exposure. Chem Res Toxicol 32(6):1027–1039. https://doi.org/10.1021/acs.chemrestox.8b00369
Ma J, Zhang W, He Y et al (2020) Clinical application of pyrrole-hemoglobin adducts as a biomarker of pyrrolizidine alkaloid exposure in humans. Arch Toxicol. https://doi.org/10.1007/s00204-020-02947-4
Macgregor JT, Wehr CM, Henika PR, Shelby MD (1990) The in vivo erythrocyte micronucleus test—measurement at steady-state increases assay efficiency and permits integration with toxicity studies. Fundam Appl Toxicol 14(3):513–522. https://doi.org/10.1016/0272-0590(90)90255-I
Mannervik B, Alin P, Guthenberg C et al (1985) Identification of three classes of cytosolic glutathione transferase common to several mammalian species: correlation between structural data and enzymatic properties. Proc Natl Acad Sci USA 82(21):7202–7206. https://doi.org/10.1073/pnas.82.21.7202
Mattocks AR (1967) Spectrophotometric determination of unsaturated pyrrolizidine alkaloids. Anal Chem 39(4):443–447. https://doi.org/10.1021/ac60248a006
Mattocks AR (1968) Toxicity of pyrrolizidine alkaloids. Nature 217(5130):723. https://doi.org/10.1038/217723a0
Mattocks AR (1971) Hepatotoxic effects due to pyrrolizidine alkaloid N-oxides. Xenobiotica 1(4):563–565. https://doi.org/10.3109/00498257109041530
Mattocks AR (1972) Acute hepatotoxicity and pyrrolic metabolites in rats dosed with pyrrolizidine alkaloids. Chem Biol Interact 5(4):227–242
Mattocks AR (1981) Relation of structural features to pyrrolic metabolites in livers of rats given pyrrolizidine alkaloids and derivatives. Chem Biol Interact 35(3):301–310. https://doi.org/10.1016/0009-2797(81)90005-3
Mattocks AR (1982) Hydrolysis and hepatotoxicity of retronecine diesters. Toxicol Lett 14(1–2):111–116. https://doi.org/10.1016/0378-4274(82)90017-0
Mattocks AR (1986) Chemistry and toxicology of pyrrolizidine alkaloids. Academic Press, London
Mattocks AR, Bird I (1983) Pyrrolic and N-oxide metabolites formed from pyrrolizidine alkaloids by hepatic microsomes in vitro: relevance to in vivo hepatotoxicity. Chem Biol Interact 43(2):209–222. https://doi.org/10.1016/0009-2797(83)90096-0
Mattocks AR, Jukes R (1990) Recovery of the pyrrolic nucleus of pyrrolizidine alkaloid metabolites from sulfur conjugates in tissues and body-fluids. Chem Biol Interact 75(2):225–239
Mattocks AR, White INH (1971) Conversion of pyrrolizidine alkaloids to n-oxides and to dihydropyrrolizine derivatives by rat-liver microsomes in-vitro. Chem Biol Interact 3(5):383–396. https://doi.org/10.1016/0009-2797(71)90018-4
Mattocks AR, Driver HE, Barbour RH, Robins DJ (1986) Metabolism and toxicity of synthetic analogues of macrocyclic diester pyrrolizidine alkaloids. Chem Biol Interact 58(1):95–108. https://doi.org/10.1016/s0009-2797(86)80089-8
Mattocks AR, Croswell S, Jukes R, Huxtable RJ (1991) Identity of a biliary metabolite formed from monocrotaline in isolated, perfused-rat-liver. Toxicon 29(4–5):409–415. https://doi.org/10.1016/0041-0101(91)90015-J
Mayer F, Luthy J (1993) Heliotrope poisoning in Tadjikistan. Lancet 342(8865):246–247. https://doi.org/10.1016/0140-6736(93)92341-p
McLean EK (1970) The toxic actions of pyrrolizidine (senecio) alkaloids. Pharmacol Rev 22(4):429–483
Mei N, Chou MW, Fu PP, Heflich RH, Chen T (2004a) Differential mutagenicity of riddelliine in liver endothelial and parenchymal cells of transgenic big blue rats. Cancer Lett 215(2):151–158. https://doi.org/10.1016/j.canlet.2004.06.013
Mei N, Heflich RH, Chou MW, Chen T (2004b) Mutations induced by the carcinogenic pyrrolizidine alkaloid riddelliine in the liver cII gene of transgenic big blue rats. Chem Res Toxicol 17(6):814–818. https://doi.org/10.1021/tx049955b
Mei N, Guo L, Zhang L et al (2006) Analysis of gene expression changes in relation to toxicity and tumorigenesis in the livers of Big Blue transgenic rats fed comfrey (Symphytum officinale). BMC Bioinform. https://doi.org/10.1186/1471-2105-7-S2-S16
Mei N, Guo L, Liu RQ, Fuscoe JC, Chen T (2007) Gene expression changes induced by the tumorigenic pyrrolizidine alkaloid riddelliine in liver of Big Blue rats. BMC Bioinform. https://doi.org/10.1186/1471-2105-8-S7-S4
Mei N, Guo L, Fu PP, Fuscoe JC, Luan Y, Chen T (2010) Metabolism, genotoxicity, and carcinogenicity of comfrey. J Toxicol Environ Health B Crit Rev 13(7–8):509–526. https://doi.org/10.1080/10937404.2010.509013
Merz KH, Schrenk D (2016) Interim relative potency factors for the toxicological risk assessment of pyrrolizidine alkaloids in food and herbal medicines. Toxicol Lett 263:44–57. https://doi.org/10.1016/j.toxlet.2016.05.002
Miranda CL, Cheeke PR, Buhler DR (1980) Comparative effects of the pyrrolizidine alkaloids jacobine and monocrotaline on hepatic drug metabolising enzymes in the rat. Res Commun Chem Pathol Pharmacol 29(3):573–587
Miranda CL, Chung WG, Reed RE et al (1991) Flavin-containing monooxygenase—a major detoxifying enzyme for the pyrrolizidine alkaloid senecionine in guinea-pig tissues. Biochem Biophys Res Commun 178(2):546–552. https://doi.org/10.1016/0006-291x(91)90142-T
Mohabbat O, Younos MS, Merzad AA, Srivastava RN, Sediq GG, Aram GN (1976) An outbreak of hepatic veno-occlusive disease in north-western Afghanistan. Lancet 308(7980):269–271
MullerTegethoff K, Kersten B, Kasper P, Muller L (1997) Application of the in vitro rat hepatocyte micronucleus assay in genetic toxicology testing. Mutat Res Genet Toxicol Environ 392(1–2):125–138. https://doi.org/10.1016/S0165-1218(97)00051-7
Ng AWT, Poon SL, Huang MN et al (2017) Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia. Sci Transl Med 9(412):eaan6446. https://doi.org/10.1126/scitranslmed.aan6446
Nigra L, Huxtable RJ (1992) Hepatic glutathione concentrations and the release of pyrrolic metabolites of the pyrrolizidine alkaloid, monocrotaline, from the isolated perfused liver. Toxicon 30(10):1195–1202. https://doi.org/10.1016/0041-0101(92)90435-8
Ning J, Rietjens I, Strikwold M (2019) Integrating physiologically based kinetic (PBK) and Monte Carlo modelling to predict inter-individual and inter-ethnic variation in bioactivation and liver toxicity of lasiocarpine. Arch Toxicol 93(10):2943–2960. https://doi.org/10.1007/s00204-019-02563-x
NTP (2008) Final report on carcinogens background document for riddelliine. National Toxicology Program, p 1–104
Pavlica D, Samuel I (1970) Primary carcinoma of the liver in Ethiopia. A study of 38 cases proved at post-mortem examination. Br J Cancer 24(1):22–29. https://doi.org/10.1038/bjc.1970.4
Pereira TN, Webb RI, Reilly PE, Seawright AA, Prakash AS (1998) Dehydromonocrotaline generates sequence-selective N-7 guanine alkylation and heat and alkali stable multiple fragment DNA crosslinks. Nucleic Acids Res 26(23):5441–5447. https://doi.org/10.1093/nar/26.23.5441
Peterson JE, Samuel A, Jago MV (1972) Pathological effects of dehydroheliotridine, a metabolite of heliotridine-based pyrrolizidine alkaloids, in the young rat. J Pathol 107(3):175–189. https://doi.org/10.1002/path.1711070305
Petry TW, Bowden GT, Huxtable RJ, Sipes IG (1984) Characterization of hepatic DNA damage induced in rats by the pyrrolizidine alkaloid monocrotaline. Cancer Res 44(4):1505–1509
Prakash AS, Pereira TN, Reilly PEB, Seawright AA (1999) Pyrrolizidine alkaloids in human diet. Mutat Res Genet Toxicol Environ 443(1–2):53–67. https://doi.org/10.1016/S1383-5742(99)00010-1
Pumford NR, Halmes NC (1997) Protein targets of xenobiotic reactive intermediates. Annu Rev Pharmacol Toxicol 37:91–117. https://doi.org/10.1146/annurev.pharmtox.37.1.91
Qiu S, Zhang H, Fei Q et al (2018) Urine and plasma metabolomics study on potential hepatoxic biomarkers identification in rats induced by Gynura segetum. J Ethnopharmacol 216:37–46. https://doi.org/10.1016/j.jep.2018.01.017
Ramsdell HS, Buhler DR (1987) Microsomal metabolism of pyrrolizidine alkaloids: N-oxidation of seneciphylline and senecionine. Toxicol Lett 37(3):241–249. https://doi.org/10.1016/0378-4274(87)90138-x
Rao MS, Reddy JK (1978) Malignant neoplasms in rats fed lasiocarpine. Br J Cancer 37(2):289–293. https://doi.org/10.1038/bjc.1978.38
Rasenack R, Muller C, Kleinschmidt M, Rasenack J, Wiedenfeld H (2003) Veno-occlusive disease in a fetus caused by pyrrolizidine alkaloids of food origin. Fetal Diagn Ther 18(4):223–225. https://doi.org/10.1159/000070799
Reed RL, Ahern KG, Pearson GD, Buhler DR (1988) Crosslinking of DNA by dehydroretronecine, a metabolite of pyrrolizidine alkaloids. Carcinogenesis 9(8):1355–1361. https://doi.org/10.1093/carcin/9.8.1355
Reed RL, Miranda CL, Kedzierski B, Henderson MC, Buhler DR (1992) Microsomal formation of a pyrrolic alcohol glutathione conjugate of the pyrrolizidine alkaloid senecionine. Xenobiotica 22(11):1321–1327. https://doi.org/10.3109/00498259209053160
Rieben WK, Coulombe RA (2004) DNA cross-linking by dehydromonocrotaline lacks apparent base sequence preference. Toxicol Sci 82(2):497–503. https://doi.org/10.1093/toxsci/kfh262
Robertson KA (1982) Alkylation of N-2 in deoxyguanosine by dehydroretronecine, a carcinogenic metabolite of the pyrrolizidine alkaloid monocrotaline. Cancer Res 42(1):8–14
Robertson KA, Seymour JL, Hsia MT, Allen JR (1977) Covalent interaction of dehydroretronecine, a carcinogenic metabolite of the pyrrolizidine alkaloid monocrotaline, with cysteine and glutathione. Cancer Res 37(9):3141–3144
Robinson O, Want E, Coen M et al (2014) Hirmi Valley liver disease: a disease associated with exposure to pyrrolizidine alkaloids and DDT. J Hepatol 60(1):96–102. https://doi.org/10.1016/j.jhep.2013.07.039
Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM (1998) DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 273(10):5858–5868. https://doi.org/10.1074/jbc.273.10.5858
Ruan J, Liao C, Ye Y, Lin G (2014a) Lack of metabolic activation and predominant formation of an excreted metabolite of nontoxic platynecine-type pyrrolizidine alkaloids. Chem Res Toxicol 27(1):7–16. https://doi.org/10.1021/tx4004159
Ruan J, Yang M, Fu P, Ye Y, Lin G (2014b) Metabolic activation of pyrrolizidine alkaloids: insights into the structural and enzymatic basis. Chem Res Toxicol 27(6):1030–1039. https://doi.org/10.1021/tx500071q
Ruan J, Gao H, Li N et al (2015) Blood pyrrole-protein adducts—a biomarker of pyrrolizidine alkaloid-induced liver Injury in humans. J Environ Sci Health C 33(4):404–421. https://doi.org/10.1080/10590501.2015.1096882
Rutz L, Gao L, Kupper JH, Schrenk D (2020) Structure-dependent genotoxic potencies of selected pyrrolizidine alkaloids in metabolically competent HepG2 cells. Arch Toxicol 94(12):4159–4172. https://doi.org/10.1007/s00204-020-02895-z
Sanderson BJ, Clark AM (1993) Micronuclei in adult and foetal mice exposed in vivo to heliotrine, urethane, monocrotaline and benzidine. Mutat Res 285(1):27–33. https://doi.org/10.1016/0027-5107(93)90048-k
Santos-Mello R, Deimling LI, Lauer CM, Almeida A (2002) Induction of micronuclei by alkaloids extracted from Senecio brasiliensis and stored for 23 years. Mutat Res Genet Toxicol Environ 516(1–2):23–28. https://doi.org/10.1016/S1383-5718(02)00008-6
Schoental R (1968) Toxicology and carcinogenic action of pyrrolizidine alkaloids. Cancer Res 28(11):2237–2246
Schoental R (1975) Pancreatic islet-cell and other tumors in rats given heliotrine, a monoester pyrrolizidine alkaloid, and nicotinamide. Cancer Res 35(8):2020–2024
Schoental R, Head MA, Peacock PR (1954) Senecio alkaloids: primary liver tumours in rats as a result of treatment with (1) a mixture of alkaloids from S. jacobaea Lin.; (2) retrorsine;(3) isatidine. Br J Cancer 8(3):458
Schrenk D, Gao L, Lin G et al (2020) Pyrrolizidine alkaloids in food and phytomedicine: occurrence, exposure, toxicity, mechanisms, and risk assessment—a review. Food Chem Toxicol 136:111107. https://doi.org/10.1016/j.fct.2019.111107
Segall HJ, Dallas JL, Haddon WF (1984) 2 Dihydropyrrolizine alkaloid metabolites isolated from mouse hepatic microsomes in vitro. Drug Metab Dispos 12(1):68–71
Sheehan D, Meade G, Foley VM, Dowd CA (2001) Structure, function and evolution of glutathione transferases: implications for classification of non-mammalian members of an ancient enzyme superfamily. Biochem J 360(Pt 1):1–16. https://doi.org/10.1042/0264-6021:3600001
Shumaker RC, Robertson KA, Hsu IC, Allen JR (1976) Neoplastic transformation in tissues of rats exposed to monocrotaline or dehydroretronecine. JNCI J Natl Cancer Inst 56(4):787–790. https://doi.org/10.1093/jnci/56.4.787
Silva-Neto JP, Barreto RA, Pitanga BPS et al (2010) Genotoxicity and morphological changes induced by the alkaloid monocrotaline, extracted from Crotalaria retusa, in a model of glial cells. Toxicon 55(1):105–117. https://doi.org/10.1016/j.toxicon.2009.07.007
Song Z, He Y, Ma J, Fu PP, Lin G (2020) Pulmonary toxicity is a common phenomenon of pyrrolizidine alkaloids. J Environ Sci Health C 38(2):124–140. https://doi.org/10.1080/26896583.2020.1743608
Stegelmeier BL, Edgar JA, Colegate SM et al (1999) Pyrrolizidine alkaloid plants, metabolism and toxicity. J Nat Toxins 8(1):95–116
Stillman AE, Huxtable R, Consroe P, Kohnen P, Smith S (1977) Hepatic veno-occlusive disease due to pyrrolizidine (Senecio) poisoning in Arizona. Gastroenterology 73(2):349–352
Wachenheim DE, Blythe LL, Craig AM (1992) Effects of antibacterial agents on in vitro ovine ruminal biotransformation of the hepatotoxic pyrrolizidine alkaloid jacobine. Appl Environ Microbiol 58(8):2559–2564. https://doi.org/10.1128/AEM.58.8.2559-2564.1992
Waizenegger J, Braeuning A, Templin M, Lampen A, Hessel-Pras S (2018) Structure-dependent induction of apoptosis by hepatotoxic pyrrolizidine alkaloids in the human hepatoma cell line HepaRG: single versus repeated exposure. Food Chem Toxicol 114:215–226. https://doi.org/10.1016/j.fct.2018.02.036
Waizenegger J, Glück J, Henricsson M, Luckert C, Braeuning A, Hessel-Pras S (2021) Pyrrolizidine alkaloids disturb bile acid homeostasis in the human hepatoma cell line heparg. Foods 10(1):161
Wang XD, Kanel GC, DeLeve LD (2000) Support of sinusoidal endothelial cell glutathione prevents hepatic veno-occlusive disease in the rat. Hepatology 31(2):428–434. https://doi.org/10.1002/hep.510310224
Wang YP, Fu PP, Chou MW (2005a) Metabolic activation of the tumorigenic pyrrolizidine alkaloid, retrorsine, leading to DNA adduct formation in vivo. Int J Environ Res Public Health 2(1):74–79. https://doi.org/10.3390/ijerph2005010074
Wang YP, Yan J, Fu PP, Chou MW (2005b) Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid. Toxicol Lett 155(3):411–420. https://doi.org/10.1016/j.toxlet.2004.11.010
Waxman DJ, Dannan GA, Guengerich FP (1985) Regulation of rat hepatic cytochrome P-450: age-dependent expression, hormonal imprinting, and xenobiotic inducibility of sex-specific isoenzymes. Biochemistry 24(16):4409–4417. https://doi.org/10.1021/bi00337a023
Weidner MF, Sigurdsson ST, Hopkins PB (1990) Sequence preferences of dna interstrand cross-linking agents: dG-to-dG cross-linking at 5′-CG by structurally simplified analogs of mitomycin-c. Biochemistry 29(39):9225–9233. https://doi.org/10.1021/bi00491a017
White INH, Mattocks AR, Butler WH (1973) Conversion of pyrrolizidine alkaloid retrorsine to pyrrolic derivatives in-vivo and in-vitro and its acute toxicity to various animal species. Chem Biol Interact 6(4):207–218. https://doi.org/10.1016/0009-2797(73)90048-3
WHO-IPCS (1988) Environmental health criteria 80, Pyrrolizidine alkaloids. World Health Organisation-International Programme on Chemical Safety, Geneva
Wiedenfeld H, Edgar JA (2011) Toxicity of pyrrolizidine alkaloids to humans and ruminants. Phytochem Rev 10(1):137–151. https://doi.org/10.1007/s11101-010-9174-0
Williams AO, Edington GM, Obakponovwe PC (1967) Hepatocellular carcinoma in infancy and childhood in Ibadan, Western Nigeria. Br J Cancer 21(3):474–482. https://doi.org/10.1038/bjc.1967.55
Williams DE, Reed RL, Kedzierski B, Dannan GA, Guengerich FP, Buhler DR (1989a) Bioactivation and detoxication of the pyrrolizidine alkaloid senecionine by cytochrome P-450 enzymes in rat liver. Drug Metab Dispos 17(4):387–392
Williams DE, Reed RL, Kedzierski B, Ziegler DM, Buhler DR (1989b) The role of flavin-containing monooxygenase in the N-oxidation of the pyrrolizidine alkaloid senecionine. Drug Metab Dispos 17(4):380–386
Williams L, Chou MW, Yan J, Young JF, Chan PC, Doerge DR (2002) Toxicokinetics of riddelliine, a carcinogenic pyrrolizidine alkaloid, and metabolites in rats and mice. Toxicol Appl Pharmacol 182(2):98–104. https://doi.org/10.1006/taap.2002.9441
Willmot F, Robertson G (1920) Senecio disease, or cirrhosis of the liver due to senecio poisoning. Lancet 196(5069):848–849
Wilson DW, Lame MW, Dunston SK, Taylor DW, Segall HJ (1998) Monocrotaline pyrrole interacts with actin and increases thrombin-mediated permeability in pulmonary artery endothelial cells. Toxicol Appl Pharmacol 152(1):138–144. https://doi.org/10.1006/taap.1998.8488
Xia Q, Chou MW, Kadlubar FF, Chan PC, Fu PP (2003) Human liver microsomal metabolism and DNA adduct formation of the tumorigenic pyrrolizidine alkaloid, riddelliine. Chem Res Toxicol 16(1):66–73. https://doi.org/10.1021/tx025605i
Xia Q, Chou MW, Lin G, Fu PP (2004) Metabolic formation of DHP-derived DNA adducts from a representative otonecine type pyrrolizidine alkaloid clivorine and the extract of Ligularia hodgsonnii hook. Chem Res Toxicol 17(5):702–708. https://doi.org/10.1021/tx030030q
Xia Q, Zhao Y, Von Tungeln LS et al (2013) Pyrrolizidine alkaloid-derived DNA adducts as a common biological biomarker of pyrrolizidine alkaloid-induced tumorigenicity. Chem Res Toxicol 26(9):1384–1396. https://doi.org/10.1021/tx400241c
Xia Q, Ma L, He X, Cai L, Fu PP (2015) 7-glutathione pyrrole adduct: a potential DNA reactive metabolite of pyrrolizidine alkaloids. Chem Res Toxicol 28(4):615–620. https://doi.org/10.1021/tx500417q
Xia Q, Zhao Y, Lin G, Beland FA, Cai L, Fu PP (2016) Pyrrolizidine alkaloid-protein adducts: potential non-invasive biomarkers of pyrrolizidine alkaloid-induced liver toxicity and exposure. Chem Res Toxicol 29(8):1282–1292. https://doi.org/10.1021/acs.chemrestox.6b00120
Xia Q, He X, Ma L, Chen S, Fu PP (2018) Pyrrolizidine alkaloid secondary pyrrolic metabolites construct multiple activation pathways leading to DNA adduct formation and potential liver tumor initiation. Chem Res Toxicol 31(7):619–628. https://doi.org/10.1021/acs.chemrestox.8b00096
Xiong A, Yang F, Fang L et al (2014) Metabolomic and genomic evidence for compromised bile acid homeostasis by senecionine, a hepatotoxic pyrrolizidine alkaloid. Chem Res Toxicol 27(5):775–786. https://doi.org/10.1021/tx400451q
Yan CC, Huxtable RJ (1995a) The effect of the pyrrolizidine alkaloids, monocrotaline and trichodesmine, on tissue pyrrole binding and glutathione metabolism in the rat. Toxicon 33(5):627–634. https://doi.org/10.1016/0041-0101(95)00004-6
Yan CC, Huxtable RJ (1995b) The relationship between the concentration of the pyrrolizidine alkaloid monocrotaline and the pattern of metabolites released from the isolated liver. Toxicol Appl Pharmacol 130(1):1–8. https://doi.org/10.1006/taap.1995.1001
Yan CC, Cooper RA, Huxtable RJ (1995) The comparative metabolism of the four pyrrolizidine alkaloids, seneciphylline, retrorsine, monocrotaline, and trichodesmine in the isolated, perfused rat liver. Toxicol Appl Pharmacol 133(2):277–284. https://doi.org/10.1006/taap.1995.1152
Yan J, Xia Q, Chou MW, Fu PP (2008) Metabolic activation of retronecine and retronecine N-oxide—formation of DHP-derived DNA adducts. Toxicol Ind Health 24(3):181–188. https://doi.org/10.1177/0748233708093727
Yang YC, Yan J, Churchwell M et al (2001a) Development of a P-32-postlabeling/HPLC method for detection of dehydroretronecine-derived DNA adducts in vivo and in vitro. Chem Res Toxicol 14(1):91–100. https://doi.org/10.1021/tx000149o
Yang YC, Yan J, Doerge DR, Chan PC, Fu PP, Chou MW (2001b) Metabolic activation of the tumorigenic pyrrolizidine alkaloid, riddelliine, leading to DNA adduct formation in vivo. Chem Res Toxicol 14(1):101–109. https://doi.org/10.1021/tx000150n
Yang M, Ruan J, Gao H et al (2017) First evidence of pyrrolizidine alkaloid N-oxide-induced hepatic sinusoidal obstruction syndrome in humans. Arch Toxicol 91(12):3913–3925. https://doi.org/10.1007/s00204-017-2013-y
Yang M, Ma J, Ruan J, Ye Y, Fu PP, Lin G (2019) Intestinal and hepatic biotransformation of pyrrolizidine alkaloid N-oxides to toxic pyrrolizidine alkaloids. Arch Toxicol 93(8):2197–2209. https://doi.org/10.1007/s00204-019-02499-2
Yang M, Ma J, Ruan J et al (2020) Absorption difference between hepatotoxic pyrrolizidine alkaloids and their N-oxides—mechanism and its potential toxic impact. J Ethnopharmacol 249:112421. https://doi.org/10.1016/j.jep.2019.112421
Zhao YW, Xia Q, da Costa GG, Yu HT, Cai LN, Fu PP (2012) Full structure assignments of pyrrolizidine alkaloid DNA adducts and mechanism of tumor initiation. Chem Res Toxicol 25(9):1985–1996. https://doi.org/10.1021/tx300292h
Zhao Y, Wang S, Xia Q et al (2014) Reaction of dehydropyrrolizidine alkaloids with valine and hemoglobin. Chem Res Toxicol 27(10):1720–1731. https://doi.org/10.1021/tx5002139
Zhou S, Chan E, Duan W, Huang M, Chen YZ (2005) Drug bioactivation, covalent binding to target proteins and toxicity relevance. Drug Metab Rev 37(1):41–213. https://doi.org/10.1081/dmr-200028812
Zhu L, Xue J, Xia Q, Fu PP, Lin G (2017) The long persistence of pyrrolizidine alkaloid-derived DNA adducts in vivo: kinetic study following single and multiple exposures in male ICR mice. Arch Toxicol 91(2):949–965. https://doi.org/10.1007/s00204-016-1713-z
Zhu L, Wang Z, Wong L et al (2018) Contamination of hepatotoxic pyrrolizidine alkaloids in retail honey in China. Food Control 85:484–494. https://doi.org/10.1016/j.foodcont.2017.10.026
Zhu L, Zhang CY, Li DP et al (2020) Tu-San-Qi (Gynura japonica): the culprit behind pyrrolizidine alkaloid-induced liver injury in China. Acta Pharmacol Sin. https://doi.org/10.1038/s41401-020-00553-9
Zhuge Y, Wang Y, Zhang F et al (2018) Clinical characteristics and treatment of pyrrolizidine alkaloid-related hepatic vein occlusive disease. Liver Int 38(10):1867–1874. https://doi.org/10.1111/liv.13684
Acknowledgements
The work was supported by Research Grants Council of Hong Kong Special Administrative Region (GRF Project nos. 14111816, 14106318, 14107719 and 14106120).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Ethical approval
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
He, Y., Zhu, L., Ma, J. et al. Metabolism-mediated cytotoxicity and genotoxicity of pyrrolizidine alkaloids. Arch Toxicol 95, 1917–1942 (2021). https://doi.org/10.1007/s00204-021-03060-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-021-03060-w